Table 3.
Cox regression multivariable analysis for DFS and OS in patients without metastasis
| DFS (3.5 years) (aHR; 95% CI) | p value | OS (4 years) (aHR; 95% CI) |
p value | |
|---|---|---|---|---|
| Age in years | 1.03 (1.01–1.06) | 0.006 | 1.07 (1.03–1.10) | <0.001 |
| Stage | 0.02 | 0.04 | ||
| Stage I | 0.45 (0.19–1.02) | 0.06 | 0.58 (0.24–1.40) | 0.22 |
| Stage II | 0.50 (0.28–0.87) | 0.015 | 0.47 (0.25–0.87) | 0.02 |
| RAS (mut. vs. wt) | 1.77 (0.96–3.27) | 0.07 | 1.91 (0.96–3.77) | 0.07 |
| BRAF (mut. vs. wt) | 0.73 (0.24–2.22) | 0.67 | 0.45 (0.16–1.32) | 0.15 |
| MMR (def. vs. pro.) | 1.00 (0.99–1.01) | 0.65 | 1.00 (0.99–1.01) | 0.48 |
Mut., mutated; wt, wild type; def., deficient; pro., proficient.